Facebook Twitter LinkedIn Instagram Email Printer Google Plus

Zhe Yu, MD, MPH

Engagement Manager, Health & Life Sciences, Oliver Wyman

The pandemic may transform the foundation that innovative collaborations are based on.

Partner, Health and Life Sciences, Oliver Wyman
Engagement Manager, Health & Life Sciences, Oliver Wyman
Principal, Oliver Wyman
Senior Consultant, Oliver Wyman

Quality, not quantity, will drive the next wave of partnerships and product launches.

Partner, Health and Life Sciences, Oliver Wyman
Principal, Oliver Wyman
Engagement Manager, Health & Life Sciences, Oliver Wyman

27 partnered products were launched last year, with 70 percent joint ventured or co-branded insurance products.

Partner, Health and Life Sciences, Oliver Wyman
Principal, Oliver Wyman
Engagement Manager, Health & Life Sciences, Oliver Wyman

As merger activity heightens, some leverage retail with pharma to meet consumer demand.

Partner, Health and Life Sciences, Oliver Wyman
Director, Marsh & McLennan Advantage, Healthcare
Engagement Manager, Health & Life Sciences, Oliver Wyman

How pharmaceutical companies can better define, measure, and deliver value to patients.

Director, Marsh & McLennan Advantage, Healthcare
Engagement Manager, Health & Life Sciences, Oliver Wyman

Insights in your inbox

Subscribe

A detailed look at the 22 new payer-provider partnerships created in Q1 this year.

Partner, Health and Life Sciences, Oliver Wyman
Partner, Health and Life Sciences, Oliver Wyman
Principal, Oliver Wyman
Engagement Manager, Health & Life Sciences, Oliver Wyman